Hiromi Ogata

1.1k total citations
22 papers, 902 citations indexed

About

Hiromi Ogata is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Hiromi Ogata has authored 22 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Hiromi Ogata's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and HIV Research and Treatment (3 papers). Hiromi Ogata is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and HIV Research and Treatment (3 papers). Hiromi Ogata collaborates with scholars based in Japan, United States and Canada. Hiromi Ogata's co-authors include Yasuhiro Koh, Kenji Maeda, Hirotomo Nakata, Hiroaki Mitsuya, Toshikazu Miyakawa, Irene T. Weber, Robert W. Harrison, Patra Volarath, Thippeswamy Devasamudram and Péter Boross and has published in prestigious journals such as Journal of Virology, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Hiromi Ogata

21 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiromi Ogata Japan 11 384 384 291 211 157 22 902
Hirotomo Nakata Japan 16 835 2.2× 805 2.1× 351 1.2× 242 1.1× 171 1.1× 29 1.3k
R W Klecker United States 11 478 1.2× 634 1.7× 435 1.5× 128 0.6× 519 3.3× 14 1.4k
Stephen M. Shaw United States 17 135 0.4× 159 0.4× 356 1.2× 256 1.2× 40 0.3× 39 1.0k
Arevik Mosoian United States 19 403 1.0× 211 0.5× 215 0.7× 314 1.5× 56 0.4× 25 1.1k
Isabelle Girault France 16 319 0.8× 181 0.5× 465 1.6× 488 2.3× 330 2.1× 39 1.2k
Eva Riveira‐Muñoz Spain 22 427 1.1× 319 0.8× 558 1.9× 397 1.9× 90 0.6× 53 1.3k
Lori A. Emert‐Sedlak United States 16 390 1.0× 272 0.7× 297 1.0× 198 0.9× 57 0.4× 23 808
Tianyu He China 17 313 0.8× 208 0.5× 169 0.6× 177 0.8× 48 0.3× 52 839
Malcolm Macartney United Kingdom 9 663 1.7× 523 1.4× 284 1.0× 217 1.0× 109 0.7× 19 1.1k
Derek J. Linderman United States 9 120 0.3× 197 0.5× 751 2.6× 227 1.1× 608 3.9× 12 1.7k

Countries citing papers authored by Hiromi Ogata

Since Specialization
Citations

This map shows the geographic impact of Hiromi Ogata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Ogata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Ogata more than expected).

Fields of papers citing papers by Hiromi Ogata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromi Ogata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Ogata. The network helps show where Hiromi Ogata may publish in the future.

Co-authorship network of co-authors of Hiromi Ogata

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Ogata. A scholar is included among the top collaborators of Hiromi Ogata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Ogata. Hiromi Ogata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nakazawa, Hikaru, Yoshikazu Tanaka, Takamitsu Hattori, et al.. (2020). Association behavior and control of the quality of cancer therapeutic bispecific diabodies expressed in Escherichia coli. Biochemical Engineering Journal. 160. 107636–107636. 4 indexed citations
3.
Asano, Ryutaro, S. KONNO, Hiromi Ogata, et al.. (2020). Build-up functionalization of anti-EGFR × anti-CD3 bispecific diabodies by integrating high-affinity mutants and functional molecular formats. Scientific Reports. 10(1). 4913–4913. 5 indexed citations
4.
Asano, Ryutaro, Keisuke Nagai, Koki Makabe, et al.. (2018). Structural considerations for functional anti-EGFR × anti-CD3 bispecific diabodies in light of domain order and binding affinity. Oncotarget. 9(17). 13884–13893. 12 indexed citations
5.
Shiotani, Masahide, Yukiko Matsumoto, Eri Okamoto, et al.. (2017). Is human chorionic gonadotropin supplementation beneficial for frozen and thawed embryo transfer in estrogen/progesterone replacement cycles?: A randomized clinical trial. Reproductive Medicine and Biology. 16(2). 166–169. 8 indexed citations
6.
Tsuji, Yukiko, Toshiroh Iwasaki, Hiromi Ogata, et al.. (2017). The Beneficial Effect of Carboxylated Poly-L-Lysine on Cryosurvival of Vitrified Early Stage Embryos.. PubMed. 38(1). 1–6. 6 indexed citations
7.
Asano, Ryutaro, Noriaki Koyama, Kyoko Arai, et al.. (2016). Anti‐EGFR scFv tetramer (tetrabody) with a stable monodisperse structure, strong anticancer effect, and a long in vivo half‐life. FEBS Open Bio. 6(6). 594–602. 10 indexed citations
8.
Sato, Masahito, Yoshinori Hamada, Miyuki Kohno, et al.. (2016). Neonatal gastrointestinal perforation in Japan: a nationwide survey. Pediatric Surgery International. 33(1). 33–41. 25 indexed citations
9.
Matsumoto, Yukiko, et al.. (2014). The effects of endometrial injury for frozen-thawed blastocyst transfer in hormone replacement cycles. Fertility and Sterility. 102(3). e56–e56. 2 indexed citations
10.
11.
Asano, Ryutaro, Takashi Kumagai, Keisuke Nagai, et al.. (2013). Domain order of a bispecific diabody dramatically enhances its antitumor activity beyond structural format conversion: the case of the hEx3 diabody. Protein Engineering Design and Selection. 26(5). 359–367. 35 indexed citations
12.
Ogata, Hiromi, et al.. (2008). Heterotopic pancreas in children: review of the literature and report of 12 cases. Pediatric Surgery International. 24(3). 271–275. 42 indexed citations
13.
Ogata, Hiromi, et al.. (2007). Familial intussusception. Journal of Pediatric Surgery. 42(9). 1509–1514. 9 indexed citations
14.
Maeda, Kenji, Hirotomo Nakata, Hiromi Ogata, et al.. (2004). The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection. Current Opinion in Pharmacology. 4(5). 447–452. 33 indexed citations
15.
Maeda, Kenji, Hirotomo Nakata, Yasuhiro Koh, et al.. (2004). Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro. Journal of Virology. 78(16). 8654–8662. 188 indexed citations
16.
Takagi, H, Takanori Kanai∥, Atsushi Okazawa, et al.. (2003). Contrasting Action of IL-12 and IL-18 in the Development of Dextran Sodium Sulphate Colitis in Mice. Scandinavian Journal of Gastroenterology. 38(8). 837–844. 138 indexed citations
17.
Koh, Yasuhiro, Hirotomo Nakata, Kenji Maeda, et al.. (2003). Novel bis -Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human Immunodeficiency Virus In Vitro. Antimicrobial Agents and Chemotherapy. 47(10). 3123–3129. 302 indexed citations
18.
Maeda, Yuichi, et al.. (2001). Treatment of Acute Spinal Epidural Hematoma.. Orthopedics & Traumatology. 50(3). 726–730.
19.
Arimizu, N, et al.. (1989). Radiation Therapy in Kimura's Disease. Acta Oncologica. 28(4). 511–514. 46 indexed citations
20.
Takeuchi, Masayasu, et al.. (1987). Effects of refined corn bran(RCB) on gastrointestinal transit time in rats and its stimulative effect on bowel movement in young women.. The Japanese Journal of Nutrition and Dietetics. 45(4). 165–171. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirotomo Nakata Breakdown of academic impact, for papers by R W Klecker Breakdown of academic impact, for papers by Stephen M. Shaw Breakdown of academic impact, for papers by Arevik Mosoian Breakdown of academic impact, for papers by Isabelle Girault Breakdown of academic impact, for papers by Eva Riveira‐Muñoz Breakdown of academic impact, for papers by Lori A. Emert‐Sedlak Breakdown of academic impact, for papers by Tianyu He Breakdown of academic impact, for papers by Malcolm Macartney Breakdown of academic impact, for papers by Derek J. Linderman
Rankless by CCL
2026